retatrutide clinical trial data Reta & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide is getting a lot

This triple receptor agonist targets three distinct hormonal pathways simultaneously, creating metabolic effects that single or dual agonist compounds cannot match

Research suggests that berberine supplementation may be an effective complementary therapy for managing Despite these positive findings, many of the studies were conducted in animals, so further research in humans is necessary to better understand the potential role of berberine in GLP-1 secretion

[DOI] [PubMed] [Google Scholar] 109.Devries S., Leib E.B

Common Gastrointestinal Side Effects of Mounjaro Gastrointestinal adverse effects are the most frequently reported side effects associated with Mounjaro therapy, particularly during dose initiation and escalation

Studies have shown that bitter-tasting pharmaceuticals and substances, including polyphenols such as isosinensetin, bind to bitter taste receptors, and unlike other TAS2R agonists, stimulate GLP-1 secretion in NCI-H716 cells [192] (Fig